Peptide Assay Transfer: Readiness, Comparability, and Documentation

Define transfer readiness

Before samples move, align method version, materials, reference standards, instruments, system suitability, analyst training, calculations, acceptance criteria, and deviation handling. A transferred method is not ready merely because a receiving analyst has run it once.

Compare transparently

Retain raw data, sample identities, replicate structure, environmental conditions, and calculations. Investigate systematic differences in recovery, response, precision, retention, or matrix behavior. Do not average away a site effect without understanding it.

Research operations

The coordinator maintains the protocol, schedule, sample map, training evidence, and review queue. Qualified analysts and quality reviewers decide whether the transfer is acceptable.

Measured evidence to preserve

ICH Q2(R2) and FDA analytical-method guidance treat accuracy, precision, specificity, range, and robustness as measured performance characteristics. A transfer record should therefore retain replicate results in the reported unit, recovery or bias, repeatability and intermediate-precision %RSD, calibration range, and the period and instruments used. Those are observations from the receiving method, not a pass/fail label supplied by a coordinator. The guidance does not provide a universal peptide-transfer result; acceptance remains method- and product-specific.

The Q2(R2) validation framework uses 3 concentrations and 3 replicates in an example structure for quantitative procedures; the resulting recovery and precision values are measured in the receiving laboratory. That design is a reporting example, not evidence that every peptide method needs exactly 9 injections.

Scope note

This is educational and not a transfer protocol.

What a comparable result must contain

An assay-transfer conclusion should show the comparison, not just the receiving laboratory's final pass statement. For a quantitative peptide assay, retain nominal and observed concentration in the method unit, recovery or bias, repeatability %RSD, intermediate-precision %RSD, calibration range, replicate count, analyst, instrument, and date. If sites use different columns, detectors, software, or sample-preparation holds, record those differences beside the result.

The Q2(R2) example structure uses three concentrations and three replicates for a quantitative procedure, while the final design remains tied to intended use. That measured design detail is useful for planning, not a universal peptide acceptance rule. A transfer coordinator can version the protocol, sample map, training record, raw-data links, and deviation queue; qualified analytical and quality owners decide whether observed bias and precision are acceptable.